Literature DB >> 22673848

Fungal keratitis responsive to moxifloxacin monotherapy.

Alice Y Matoba1.   

Abstract

PURPOSE: To report 5 cases of culture-proven fungal keratitis that resolved with moxifloxacin monotherapy.
METHODS: Case reports and review of medical literature. Five patients with fungal keratitis were treated with topical moxifloxacin.
RESULTS: All 5 patients had resolution of their infection with topical moxifloxacin monotherapy.
CONCLUSIONS: Topical fluoroquinolone agents may have significant antifungal properties. However, the vast majority of fungal keratitis patients cannot be cured with fluoroquinolone monotherapy. An initial response of keratitis to topical fluoroquinolone therapy should not lead to the assumption that the infection is bacterial because the possibility of fungal infection cannot be ruled out on that basis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22673848      PMCID: PMC3436968          DOI: 10.1097/ICO.0b013e31823f766c

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  14 in total

Review 1.  Quinolones in 2005: an update.

Authors:  F Van Bambeke; J-M Michot; J Van Eldere; P M Tulkens
Journal:  Clin Microbiol Infect       Date:  2005-04       Impact factor: 8.067

Review 2.  DNA topoisomerase inhibitors as antifungal agents.

Authors:  L L Shen; J M Fostel
Journal:  Adv Pharmacol       Date:  1994

3.  An outbreak of Fusarium keratitis associated with contact lens wear in Singapore.

Authors:  Wei-Boon Khor; Tin Aung; Seang-Mei Saw; Tien-Yin Wong; Paul A Tambyah; Ai-Ling Tan; Roger Beuerman; Li Lim; Wing-Kwong Chan; Wee-Jin Heng; Jimmy Lim; Raymond S K Loh; Sao-Bing Lee; Donald T H Tan
Journal:  JAMA       Date:  2006-06-28       Impact factor: 56.272

4.  Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs.

Authors:  A M Sugar; X P Liu; R J Chen
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

5.  Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus.

Authors:  Theodouli Stergiopoulou; Joseph Meletiadis; Tin Sein; Paraskevi Papaioannidou; Ioannis Tsiouris; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

6.  Characterization of DNA topoisomerase I from Candida albicans as a target for drug discovery.

Authors:  J M Fostel; D A Montgomery; L L Shen
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

7.  In-vitro activity of antifungal agents in combination with four quinolones.

Authors:  M A Petrou; T R Rogers
Journal:  Drugs Exp Clin Res       Date:  1988

8.  A case series of contact lens-associated Fusarium keratitis in Hong Kong.

Authors:  Srinivas K Rao; Philip T H Lam; Emmy Y M Li; Hunter K L Yuen; Dennis S C Lam
Journal:  Cornea       Date:  2007-12       Impact factor: 2.651

9.  Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy.

Authors:  Wuqaas M Munir; Steven I Rosenfeld; Ira Udell; Darlene Miller; Carol L Karp; Eduardo C Alfonso
Journal:  Cornea       Date:  2007-06       Impact factor: 2.651

10.  In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi.

Authors:  R Nakajima; A Kitamura; K Someya; M Tanaka; K Sato
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

View more
  4 in total

1.  The antibacterial agent, moxifloxacin inhibits virulence factors of Candida albicans through multitargeting.

Authors:  Ashwini Jadhav; Bhagyashree Bansode; Datta Phule; Amruta Shelar; Rajendra Patil; Wasudev Gade; Kiran Kharat; Sankunny Mohan Karuppayil
Journal:  World J Microbiol Biotechnol       Date:  2017-04-13       Impact factor: 3.312

2.  Fungal keratitis: study of increasing trend and common determinants.

Authors:  Yogesh Acharya; Bhawana Acharya; Priyanka Karki
Journal:  Nepal J Epidemiol       Date:  2017-06-30

Review 3.  Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?

Authors:  A Dalhoff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-17       Impact factor: 3.267

4.  Fungal keratitis due to Scopulariopsis brevicaulis and a potential promising therapeutic effect of antibacterial agents: A case report.

Authors:  Nasser M Kaplan; Rami A Al-Dwairi; Nasr N AlRabadi
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.